Profile data is unavailable for this security.
About the company
Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are predominantly differentiated by safety and improved patient outcomes. UTMD’s products include Blood Monitoring, which includes Deltran Disposable Blood Pressure Transducers, Deltran Plus Arterial Blood Sampling Systems, and Deltran Accessories; Electrosurgery, which includes Epitome Electrosurgical Scalpels, OptiMicro Ultra-Fine Tip Electrosurgical Needles, Finesse+ Electrosurgical Generators, Filtresse Surgical Smoke Evacuation Systems and Finesse+ Accessories; Labor and Delivery, which includes AROM-Cot, BT-Cath, CVX-Ripe, Intran, Muc-X and Cordguard; Neonatal Intensive Care, which includes Hemo-Nate, Thora-Cath, Nutri-Cath, Nutri-Lok, Myelo-Nate, Disposa-Hood, Neonatal Deltran, Pala-Nate, PICC-Nate, Dialy-Nate, Umbili-Cath and Uri-Cath; Urological Care, which includes the Liberty, Supra-Foley, and Pathfinder Plus; Womens Pelvic Health, and original equipment manufacturer/Capabilities.
- Revenue in USD (TTM)--
- Net income in USD--
- Incorporated1978
- Employees178.00
- LocationUtah Medical Products Inc7043 S 300 WestMIDVALE 84047United StatesUSA
- Phone+1 (801) 566-1200
- Fax+1 (801) 566-7305
- Websitehttp://www.utahmed.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eargo Inc | 34.39m | -159.21m | 243.67m | 257.00 | -- | -- | -- | 7.09 | -80.92 | -80.92 | 17.48 | -18.43 | 0.2167 | 4.25 | 4.27 | 133,817.10 | -100.31 | -- | -343.16 | -- | 30.57 | -- | -462.95 | -- | 0.6427 | -5.25 | 1.41 | -- | -3.81 | -- | -425.58 | -- | -- | -- |
| Semler Scientific Inc | 54.43m | 12.62m | 261.97m | 124.00 | 24.26 | 4.88 | 19.79 | 4.81 | 1.58 | 1.58 | 6.76 | 7.85 | 0.973 | 4.55 | 14.24 | 438,975.80 | 22.55 | 54.29 | 26.06 | 71.86 | 90.38 | 88.38 | 23.18 | 31.46 | 6.10 | -- | 0.00 | -- | 37.36 | 48.13 | 22.95 | -- | 0.2688 | -- |
| Tactile Systems Technology Inc | 234.61m | -29.98m | 262.62m | 988.00 | -- | 2.30 | -- | 1.12 | -1.50 | -1.50 | 11.74 | 5.68 | 0.9424 | 5.21 | 4.88 | 237,462.50 | -12.04 | 1.80 | -14.59 | 2.12 | 47.95 | 48.68 | -12.78 | 1.46 | 1.68 | -- | 0.3024 | 0.00 | 11.18 | 19.74 | -1,805.00 | -- | 23.10 | -- |
| SmileDirectClub Inc | 510.50m | -93.82m | 272.64m | 3.20k | -- | 2.15 | -- | 0.5341 | -0.7803 | -0.7803 | 4.24 | 0.3241 | 0.6726 | 3.69 | 2.93 | 159,530.60 | -40.03 | -- | -32.26 | -- | 69.93 | -- | -59.51 | -- | 1.99 | -19.68 | 1.68 | -- | -2.92 | -- | -30.72 | -- | -- | -- |
| Accuray Inc | 417.45m | -11.82m | 281.34m | 1.04k | -- | 5.54 | -- | 0.674 | -0.1265 | -0.1265 | 4.47 | 0.5419 | 0.8842 | 1.88 | 4.88 | 399,851.50 | -2.50 | 0.4157 | -4.26 | 0.744 | 37.22 | 39.04 | -2.83 | 0.4555 | 0.9814 | 0.323 | 0.7765 | 0.00 | 8.48 | 2.32 | 15.27 | -- | -2.54 | -- |
| Orchestra Biomed Holdings Inc | 0.00 | -2.74m | 283.26m | -- | -- | 1.65 | -- | -- | -0.1855 | -0.1855 | 0.00 | 5.42 | 0.00 | -- | -- | -- | -2.38 | -- | -2.40 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -622.14 | -- | -- | -- |
| ZimVie Inc | 946.34m | -94.24m | 284.62m | 2.70k | -- | 0.3879 | 8.83 | 0.3008 | -3.61 | -3.61 | 36.27 | 28.13 | 0.5505 | 1.41 | 5.79 | 350,497.00 | -5.48 | -- | -6.24 | -- | 62.76 | -- | -9.96 | -- | 1.48 | -7.69 | 0.4282 | -- | 11.20 | -- | 46.79 | -- | -- | -- |
| Agape ATP Corp | 1.68m | -1.93m | 302.56m | 36.00 | -- | 135.44 | -- | 180.13 | -0.0137 | -0.0137 | 0.0103 | 0.0296 | 0.4017 | 1.30 | 94.74 | 46,657.50 | -45.94 | -- | -57.89 | -- | 70.95 | -- | -114.34 | -- | 2.45 | -4.88 | 0.00 | -- | -70.55 | -- | -811.51 | -- | -- | -- |
| Pulmonx Corp | 51.95m | -57.65m | 329.58m | 253.00 | -- | 2.02 | -- | 6.34 | -1.56 | -1.56 | 1.41 | 4.37 | 0.2314 | 0.8518 | 7.35 | 205,316.20 | -25.68 | -- | -28.46 | -- | 74.95 | -- | -110.98 | -- | 7.73 | -54.68 | 0.0961 | -- | 47.91 | -- | -50.98 | -- | -- | -- |
| Utah Medical Products, Inc. | -100.00bn | -100.00bn | 341.43m | 178.00 | -- | 2.99 | -- | -- | -- | -- | -- | 31.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 14.10 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Vuzix Corp | 12.25m | -47.02m | 366.50m | 106.00 | -- | 2.92 | -- | 29.91 | -0.738 | -0.738 | 0.1923 | 1.97 | 0.0833 | 0.9145 | 5.36 | 115,583.60 | -31.96 | -55.33 | -33.30 | -60.69 | 17.48 | 2.36 | -383.75 | -280.39 | 11.78 | -- | 0.00 | -- | 13.67 | 43.98 | -101.80 | -- | 17.29 | -- |
| Edap Tms SA (ADR) | 57.60m | 3.85m | 393.26m | 227.00 | 106.18 | 4.91 | -- | 6.83 | 0.1025 | 0.1025 | 1.56 | 2.22 | 0.598 | 3.34 | 4.22 | 253,729.60 | 3.99 | -0.1923 | 5.02 | -0.2881 | 43.45 | 43.55 | 6.68 | -0.2486 | 3.92 | -- | 0.0661 | -- | 5.77 | 4.35 | 141.08 | -28.86 | 0.5449 | -- |
| CVRx Inc | 22.47m | -41.43m | 400.29m | 109.00 | -- | 3.67 | -- | 17.82 | -2.02 | -2.02 | 1.09 | 5.29 | 0.162 | 0.9226 | 5.57 | -- | -29.86 | -- | -31.45 | -- | 77.75 | -- | -184.38 | -- | 14.33 | -257.74 | 0.0582 | -- | 72.36 | -- | 3.83 | -- | -- | -- |
| AxoGen Inc | 133.96m | -28.82m | 418.64m | 428.00 | -- | 4.13 | -- | 3.13 | -0.6882 | -0.6882 | 3.20 | 2.40 | 0.6607 | 1.53 | 6.71 | 312,983.70 | -14.21 | -16.05 | -16.07 | -18.36 | 80.29 | 80.83 | -21.51 | -22.98 | 3.54 | -- | 0.3097 | -- | 13.41 | 25.38 | -13.45 | -- | 89.66 | -- |
| SurModics, Inc. | 99.95m | -27.27m | 423.07m | 447.00 | -- | 3.88 | -- | 4.23 | -1.96 | -1.96 | 7.18 | 7.73 | 0.5664 | 2.19 | 5.91 | 223,604.00 | -15.45 | -2.06 | -18.74 | -2.42 | 79.65 | 83.39 | -27.29 | -3.57 | 1.43 | -55.80 | 0.0845 | -- | -4.93 | 6.45 | -743.71 | -- | -12.13 | -- |
| Meihua International Medical Tech Co Ltd | -100.00bn | -100.00bn | 436.23m | 622.00 | -- | 2.67 | -- | -- | -- | -- | -- | 5.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.40 | -- | 0.0375 | -- | 16.82 | -- | 10.00 | -- | -- | -- |
Data as of Feb 03 2023. Currency figures normalised to Utah Medical Products Inc's reporting currency: US Dollar USD
49.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 30 Sep 2022 | 380.09k | 10.48% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2022 | 342.19k | 9.43% |
| Renaissance Technologies LLCas of 30 Sep 2022 | 216.51k | 5.97% |
| BlackRock Fund Advisorsas of 30 Sep 2022 | 179.26k | 4.94% |
| The Vanguard Group, Inc.as of 30 Sep 2022 | 160.71k | 4.43% |
| Dimensional Fund Advisors LPas of 30 Sep 2022 | 152.92k | 4.22% |
| Rice, Hall, James & Associates LLCas of 31 Dec 2022 | 114.37k | 3.15% |
| JPMorgan Investment Management, Inc.as of 30 Sep 2022 | 88.75k | 2.45% |
| Healthinvest Partners ABas of 30 Sep 2022 | 86.00k | 2.37% |
| Ranger Investment Management LPas of 30 Sep 2022 | 73.57k | 2.03% |
More ▼
Data from 30 Sep 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
